![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Department of Food Science and Human Nutrition, Iowa State University, Ames, IA 50011
2To whom correspondence should be addressed. E-mail: shendric{at}iastate.edu.
Three experiments were conducted to characterize the metabolism of isoflavones from soy milk in women: two meals in 2 wk separated by a 1-wk washout period (Experiment 1), one meal feeding (Experiment 2) and six consecutive days of feeding (Experiment 3). Urine and plasma samples were extracted directly or predigested before extraction with H-2 ß-glucuronidase/sulfatase or B-3 ß-glucuronidase so that isoflavone glucuronide and sulfate conjugates could be determined by difference. Among the three experiments, no significant differences were found in the proportion of glucuronide, sulfate and aglycone isoflavones recovered from plasma samples taken 3 h after isoflavone dosing or in 24-h urine samples taken after isoflavone dosing. In the 6-d feeding study, samples taken on d 5 and 6 did not differ significantly in isoflavone content or proportion of the metabolites studied. The percentages of daidzein and genistein glucuronides were 73 ± 4 and 71 ± 5% of total daidzein and genistein excreted in urine, and 62 ± 4 and 53 ± 6% of total daidzein and genistein present in plasma, respectively. Percentages of aglycone daidzein and genistein were 4 ± 1 and 5 ± 1% of total daidzein and genistein in urine, and 18 ± 2 and 26 ± 7% of total daidzein and genistein present in plasma, respectively. These studies showed that about one fifth of circulating isoflavones are aglycones. Concentrations of isoflavones chosen for in vitro studies should take this into account. Because the glucuronide isoflavones predominate in vivo, these metabolites should not be overlooked as possible contributors to observed effects of isoflavones.
KEY WORDS: • glucuronide • aglycone • isoflavone • humans
This article has been cited by other articles:
|
|
 |
|
  D Pugazhendhi, K A Watson, S Mills, N Botting, G S Pope, and P D Darbre Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells J. Endocrinol., June 1, 2008; 197(3): 503 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Fraser, E. Beyret, S. R. Milligan, and S. A. Adeoya-Osiguwa Effects of estrogenic xenobiotics on human and mouse spermatozoa Hum. Reprod., May 1, 2006; 21(5): 1184 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Harris, E. Besselink, S. M. Henning, V. L. W. Go, and D. Heber Phytoestrogens Induce Differential Estrogen Receptor Alpha- or Beta-Mediated Responses in Transfected Breast Cancer Cells Experimental Biology and Medicine, September 1, 2005; 230(8): 558 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Chacko, R. T. Chandler, A. Mundhekar, N. Khoo, H. M. Pruitt, D. F. Kucik, D. A. Parks, C. G. Kevil, S. Barnes, and R. P. Patel Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H908 - H915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A Kroon, M. N Clifford, A. Crozier, A. J Day, J. L Donovan, C. Manach, and G. Williamson How should we assess the effects of exposure to dietary polyphenols in vitro? Am. J. Clinical Nutrition, July 1, 2004; 80(1): 15 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Imai, S. Tsukahara, S. Asada, and Y. Sugimoto Phytoestrogens/Flavonoids Reverse Breast Cancer Resistance Protein/ABCG2-Mediated Multidrug Resistance Cancer Res., June 15, 2004; 64(12): 4346 - 4352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Polyphenols: food sources and bioavailability Am. J. Clinical Nutrition, May 1, 2004; 79(5): 727 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Wu, M. C. Yu, C.-C. Tseng, N. C. Twaddle, and D. R. Doerge Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County Carcinogenesis, January 1, 2004; 25(1): 77 - 81. [Abstract] [Full Text] [PDF]
|
|
